Рет қаралды 929
Welcome to Living With… a KZfaq series presented by Hypersomnia Foundation. In this episode, Claire Wylds-Wright, CEO of Hypersomnia Foundation, sits down with Dr. Thomas Scammell, a Professor in Neurology at Harvard Medical School, Beth Israel Deaconess Medical Center, and Boston Children's Hospital.
For the last 25 years, Dr. Scammell has run a research lab at Beth Israel Deaconess and focused on identifying the brain mechanisms that control sleep and wakefulness. He has received several National Institutes of Health (NIH) grants for this work. One of his lab's main focuses is orexin, a neurotransmitter that helps wakefulness and cataplexy.
In this episode, Dr. Scammell and Claire discuss current medicines available for symptom management of idiopathic hypersomnia, his current research around idiopathic hypersomnia, and how that impacts upcoming medicines and opportunities for our community.
Watch now for Dr. Scammell’s deep dive into current medicines for sleepiness and morning sleep inertia. We appreciate his clinical work and research aimed at improving quality of life for people with idiopathic hypersomnia.
Living With… is hosted by Claire Wylds-Wright with the Hypersomnia Foundation. It is produced by Elizabeth Joy Windom of Windhaven Productions.
A special thanks to our sponsors!
Platinum Sponsor - Jazz Pharmaceuticals
Gold Sponsors - Avadel Pharmaceuticals and Harmony Biosciences
Bronze Sponsors - Zevra Therapeutics and Takeda Pharmaceuticals
Sponsor - Centessa Pharmaceuticals